TwitterLinkedInYoutubeSlideshareflickrIFPMA - Global Health Matters - BlogRSS
IFPMA Home

International Federation of Pharmaceutical Manufacturers & Associations



Phriday Pharma Phacts

Phriday Pharma Phact 17

More than 350 million patients worldwide are leading healthier lives thanks to biotherapeutic medicines

Read more here

Brings you a weekly dose of key facts about the research-based pharmaceutical industry every week!

This collection of interesting and useful facts relating to the pharmaceutical industry provides a snapshot and reminder of the work the industry undertakes. This includes information about biopharmaceutical innovation and global health, access to medicines and healthcare systems, as well as the positive economic footprint of the pharmaceutical industry.

These facts underscore the role of the research-based pharmaceutical industry as one of the most innovative sectors. Over the past century the industry has played a unique role in developing new and improved medicines and vaccines to prevent and treat diseases and contributing to significant health advances.

Phriday Pharma Phact 1

Phriday Pharma Phact Week 1: Out of all the industrial sectors, the pharmaceutical industry consistently invests the most in R&D Read more here

Phriday Pharma Phact 2

Ph3 Phriday Pharma Phact 2: The Pharmaceutical industry is the 3rd largest global funder of R&D for NTDs Read more here

Phriday Pharma Phact 3

There are 3073 projects in the pipeline for cancer treatments Read more here

Phriday Pharma Phact 4

“There are 450 medicines under development for cardiovascular diseases” Read more here

Phriday Pharma Phact 5

The Pharmaceutical industry provides 100 clinics in Mozambique with mHealth tools Read more here

Phriday Pharma Phact 6

132 of our over 220 developing world health partnerships are R&D projects to develop new medicines and vaccines for NTDs Read more here

Phriday Pharma Phact 7

132 of our 220 health partnerships focus on women and children Read more here

Phriday Pharma Phact 8

250 tests are carried out on biotherapeutics compared to 50 tests for chemical medicines Read more here

Phriday Pharma Phact 9

7 Million hours of work are needed to produce one safe, effective and high quality medicinal product Read more here

Phriday Pharma Phact 10

In 2011 the Pharmaceutical industry contributed 23.4% of overall research funding for TB Read more here

Phriday Pharma Phact 11

Vaccine development costs from 200-900 USD million and can take from 8-18.5 years Read more here

Phriday Pharma Phact 12

In 2011 IFPMA members pledged donations of 1.4 billion treatments annually for neglected tropical diseases (NTDs) Read more here

Phriday Pharma Phact 13

Quality Control represents up to 70% of the manufacturing time for vaccines Read more here

Phriday Pharma Phact 14

Malaria kills approx. 627,000 people a year worldwide! Read more here

Phriday Pharma Phact 15

For each 24 USD spent on new drugs for cardiovascular diseases 89 USD is saved in hospital costs Read more here

Phriday Pharma Phact 16

The cost of researching and developing a new chemical or biologic was USD 1.3 billion in 2011 Read more here

Phriday Pharma Phact 17

More than 350 million patients worldwide are leading healthier lives thanks to biotherapeutic medicines Read more here

Phriday Pharma Phact 18

Every year drugs and vaccines prevent 3 million deaths from malaria Read more here

Phriday Pharma Phact 19

Difficulties of drug discovery-35 new medicines were launched in 2011 from more than 3,200 compounds in development Read more here